Adaptimmune Therapeutics plc (ADAP)
NASDAQ: ADAP · Real-Time Price · USD
0.2060
-0.0140 (-6.36%)
At close: Mar 28, 2025, 4:00 PM
0.2048
-0.0012 (-0.58%)
After-hours: Mar 28, 2025, 4:55 PM EDT
Adaptimmune Therapeutics Market Cap
Adaptimmune Therapeutics has a market cap or net worth of $52.99 million as of March 28, 2025. Its market cap has decreased by -85.59% in one year.
Market Cap
52.99M
Enterprise Value
-23.51M
1-Year Change
-85.59%
Ranking
Category
Stock Price
$0.21
Market Cap Chart
Since March 31, 2016, Adaptimmune Therapeutics's market cap has decreased from $575.60M to $52.99M, a decrease of -90.79%. That is a compound annual growth rate of -23.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2025 | 56.60M | -58.96% |
| Dec 31, 2024 | 137.90M | -23.43% |
| Dec 29, 2023 | 180.10M | -24.71% |
| Dec 30, 2022 | 239.20M | -59.17% |
| Dec 31, 2021 | 585.90M | -29.78% |
| Dec 31, 2020 | 834.40M | 561.17% |
| Dec 31, 2019 | 126.20M | -79.02% |
| Dec 31, 2018 | 601.40M | -3.93% |
| Dec 29, 2017 | 626.00M | 118.35% |
| Dec 30, 2016 | 286.70M | -50.19% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition